IMPROVE-IT: Implications for clinical practice & guidelines
Prof. Kausik Ray, London, provides a perspective on the results of the IMPROVE-IT Trial and its implications for current clinical practice, guidelines and future LDL-c lowering therapies
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: